Posted by Michael Wonder on 29 Jul 2019
FDA’s Sharpless outlines FDA's 4 top priorities: tech, hiring, modernisation and increased safety
24 July 2019 - Acting U.S. FDA Commissioner Ned Sharpless emailed agency staff yesterday outlining the FDA’s four main priorities.
The four top priorities are:
- Assuring public health by using emerging technologies.
- Investing in the agency’s next-generation workforce and infrastructure.
- Modernising frameworks.
- Promoting and protecting consumer and patient safety.
“We see the promise of technologies like 3D-printed devices, cell-cultured food, cell-based therapeutics and intentional genomic alternations to animals and plants to deliver enormous benefits to public health,” Sharpless wrote. “As these fascinating technologies are developed, however, the FDA will also need to augment its expertise in these areas to afford optimal review and regulation of products derived from cutting-edge technology.”
